Editorial: Advances in epithelial ovarian cancer: model systems, microenvironmental influences, therapy, and origins

被引：1
|
作者：
Howell, Viive Maarika [1 ,2 ]
Davidson, Ben [3 ]
机构：
[1] Kolling Inst, Bill Walsh Translat Canc Res Lab, St Leonards, NSW, Australia
[2] Univ Sydney, Sydney Med Sch Northern, Sydney, NSW 2006, Australia
[3] Oslo Univ Hosp, Norwegian Radium Hosp, Oslo, Norway
来源：
FRONTIERS IN ONCOLOGY | 2015年 / 5卷
关键词：
ovarian cancer; mouse models; microenvironment; chemoresistance; ascites; 3D culture models; CARCINOMA; BRCA;
D O I：
10.3389/fonc.2015.00205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Recurrent epithelial ovarian cancer and hormone therapy
    Yokoyama, Yoshihito
    Mizunuma, Hideki
    WORLD JOURNAL OF CLINICAL CASES, 2013, 1 (06) : 187 - 190
  • [32] ADJUVANT THERAPY IN EPITHELIAL OVARIAN-CANCER
    RATNER, IA
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (11): : 775 - 775
  • [33] SALVAGE THERAPY IN EPITHELIAL OVARIAN-CANCER
    CALDAS, C
    MORRIS, LE
    MCGUIRE, WP
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1994, 21 (01) : 179 - 194
  • [34] Epithelial ovarian cancer: Focus on targeted therapy
    Pliarchopoulou, Kyriaki
    Pectasides, Dimitrios
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 79 (01) : 17 - 23
  • [35] Recurrent epithelial ovarian cancer and hormone therapy
    Yoshihito Yokoyama
    Hideki Mizunuma
    World Journal of Clinical Cases, 2013, (06) : 187 - 190
  • [36] TAMOXIFEN THERAPY OF EPITHELIAL OVARIAN-CANCER
    SHIREY, DR
    KAVANAGH, JJ
    GERSHENSON, DM
    FREEDMAN, RS
    COPELAND, LJ
    JONES, LA
    OBSTETRICS AND GYNECOLOGY, 1985, 66 (04): : 575 - 578
  • [37] Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems
    Patra, Bishnubrata
    Lateef, Muhammad Abdul
    Brodeur, Melica Nourmoussavi
    Fleury, Hubert
    Carmona, Euridice
    Peant, Benjamin
    Provencher, Diane
    Mes-Masson, Anne-Marie
    Gervais, Thomas
    PLOS ONE, 2020, 15 (12):
  • [38] Reclassifying ovarian cancer: origins, subtypes and resistance to therapy
    DDL Bowtell
    Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
  • [39] Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer
    Wilson, Andrew J.
    Saskowski, Jeanette
    Barham, Whitney
    Khabele, Dineo
    Yull, Fiona
    MOLECULAR CANCER, 2015, 14
  • [40] Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer
    Andrew J. Wilson
    Jeanette Saskowski
    Whitney Barham
    Dineo Khabele
    Fiona Yull
    Molecular Cancer, 14
12345